Centogene N.V.

NASDAQ:CNTG

0.325 (USD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 012.31212.31213.04213.04211.19810.32742.89630.19651.87164.9670.25236.3059.71912.10515.22111.63811.20610.71510.08613.388.5068.5068.753
Cost of Revenue 07.8647.8647.2597.2596.5866.4530.4435.61843.7651.94746.48626.0596.8157.0186.5066.6416.1146.7444.2436.5724.5634.5632.513
Gross Profit 04.4484.4485.7835.7834.6123.87712.456-5.4228.11113.01323.76610.2462.9045.0878.7154.9975.0923.9715.8436.8083.9433.9436.24
Gross Profit Ratio 00.3610.3610.4430.4430.4120.3750.29-0.180.1560.20.3380.2820.2990.420.5730.4290.4540.3710.5790.5090.4640.4640.713
Reseach & Development Expenses 03.4263.4264.2094.2094.4574.6147.0883.8214.0534.3354.3294.7963.1192.6913.4712.0112.4071.7012.5171.4271.1781.1783.546
General & Administrative Expenses 08.5868.5867.6527.6529.3787.90612.29410.40610.49411.59613.6278.3737.7677.8986.6734.8845.6935.914.0875.4934.5154.5151.463
Selling & Marketing Expenses 03.353.352.3662.3662.7982.3943.7632.2061.9421.9491.5681.32.3862.3263.111.7882.3452.0112.8351.7911.4241.4242.179
SG&A 012.18412.18410.26110.26112.17610.316.05712.61212.43613.54515.1959.67310.15310.2249.7836.6728.0387.9216.9227.2845.9395.9393.642
Other Expenses 00000-0.15102.5040000.56000000000000
Operating Expenses 015.29615.29613.42113.42116.48214.18124.72515.56115.22317.51419.53913.84313.00813.24513.78.37211.1778.8668.5537.946.9736.9737.202
Operating Income 0-10.627-10.627-7.268-7.268-11.87-10.459-12.368-21.346-7.684-4.633.303-4.744-10.104-8.158-4.861-2.843-6.085-4.895-3.414-1.132-2.933-2.933-0.971
Operating Income Ratio 0-0.863-0.863-0.557-0.557-1.06-1.013-0.288-0.707-0.148-0.0710.047-0.131-1.04-0.674-0.319-0.244-0.543-0.457-0.338-0.085-0.345-0.345-0.111
Total Other Income Expenses Net 0-1.595-1.595-0.586-0.5860.158-0.6211.754-0.2635.271-0.293-4.544-0.793-0.293-0.449-0.16-0.993-0.207-0.212-0.125-0.245-0.434-0.4340
Income Before Tax 0-12.222-12.222-7.854-7.854-11.712-11.079-12.482-21.609-7.896-4.8893.407-5.537-10.36-8.607-5.021-4.276-6.292-5.107-3.539-1.377-3.366-3.366-0.971
Income Before Tax Ratio 0-0.993-0.993-0.602-0.602-1.046-1.073-0.291-0.716-0.152-0.0750.048-0.153-1.066-0.711-0.33-0.367-0.561-0.477-0.351-0.103-0.396-0.396-0.111
Income Tax Expense 00.0070.0070.0360.0360.1750.004-0.1830.0350.1240.2590.0490.1030.0130.129-0.0051.433-0.0110.174-0.048-0.1520.0550.0550.023
Net Income 0-12.228-12.228-7.818-7.818-11.887-6.482-12.299-21.644-8.02-4.8893.358-5.64-10.36-8.736-5.016-4.276-6.281-5.281-3.491-1.225-3.311-3.311-0.994
Net Income Ratio 0-0.993-0.993-0.599-0.599-1.062-0.628-0.287-0.717-0.155-0.0750.048-0.155-1.066-0.722-0.33-0.367-0.561-0.493-0.346-0.092-0.389-0.389-0.114
EPS 0-0.44-0.44-0.29-0.29-0.44-0.28-0.54-0.96-0.37-0.220.15-0.27-0.52-0.43-0.25-0.22-0.32-0.27-0.18-0.062-12.5-12.5-4.32
EPS Diluted 0-0.44-0.44-0.29-0.29-0.44-0.28-0.54-0.96-0.36-0.220.15-0.27-0.52-0.43-0.25-0.22-0.32-0.27-0.18-0.062-12.5-12.5-4.32
EBITDA 0-8.726-8.726-6.055-5.466-9.72-6.65-4.813-14.54-9.783-10.5511.126-2.233-7.743-6.074-2.739-1.231-4.619-3.496-1.8680.314-1.832-1.832-0.403
EBITDA Ratio 0-0.709-0.709-0.464-0.419-0.868-0.629-0.104-0.469-0.072-0.0190.177-0.03-0.797-0.502-0.188-0.151-0.412-0.326-0.1150.023-0.215-0.215-0.046